434 related articles for article (PubMed ID: 30817557)
21. Breast Implant-associated Anaplastic Large Cell Lymphoma.
Alotaibi S; Hamadani M; Al-Mansour M; Aljurf M
Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e272-e276. PubMed ID: 33384263
[TBL] [Abstract][Full Text] [Related]
22. Cellular and Molecular Mechanisms of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
DeCoster RC; Clemens MW; Di Napoli A; Lynch EB; Bonaroti AR; Rinker BD; Butterfield TA; Vasconez HC
Plast Reconstr Surg; 2021 Jan; 147(1):30e-41e. PubMed ID: 33370049
[TBL] [Abstract][Full Text] [Related]
23. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Clinical Update.
Skelly A; Guo L
Ann Plast Surg; 2021 Mar; 86(3S Suppl 2):S154-S158. PubMed ID: 33346558
[TBL] [Abstract][Full Text] [Related]
24. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and the Textured Breast Implant Crisis.
K Groth A; Graf R
Aesthetic Plast Surg; 2020 Feb; 44(1):1-12. PubMed ID: 31624894
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Deva A; Xu H; Morgan J; Khare P; MacLeod RA; Van Natta BW; Adams WP; Brody GS; Epstein AL
Aesthet Surg J; 2016 Jul; 36(7):773-81. PubMed ID: 26979456
[TBL] [Abstract][Full Text] [Related]
26. Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
O'Neill AC; Zhong T; Hofer SOP
Ann Surg Oncol; 2017 Oct; 24(11):3174-3179. PubMed ID: 28762113
[TBL] [Abstract][Full Text] [Related]
27. Breast Implant and Anaplastic Large Cell Lymphoma Meta-Analysis.
Ramos-Gallardo G; Cuenca-Pardo J; Rodríguez-Olivares E; Iribarren-Moreno R; Contreras-Bulnes L; Vallarta-Rodríguez A; Kalixto-Sanchez M; Hernández C; Ceja-Martinez R; Torres-Rivero C
J Invest Surg; 2017 Feb; 30(1):56-65. PubMed ID: 27537783
[TBL] [Abstract][Full Text] [Related]
28. Risk of breast implant-associated anaplastic large cell lymphoma in patients submitted to breast implantation: A systematic review.
Wohlgemuth FB; Brasil MBQ; d'Acampora AJ
Breast J; 2019 Sep; 25(5):932-937. PubMed ID: 31155830
[TBL] [Abstract][Full Text] [Related]
29. Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings, 2012-2018.
McCarthy CM; Loyo-Berríos N; Qureshi AA; Mullen E; Gordillo G; Pusic AL; Ashar BS; Sommers K; Clemens MW
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):65S-73S. PubMed ID: 30817558
[TBL] [Abstract][Full Text] [Related]
30. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
[TBL] [Abstract][Full Text] [Related]
31. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
[TBL] [Abstract][Full Text] [Related]
32. Anaplastic large T-cell lymphoma and breast implants: a review of the literature.
Jewell M; Spear SL; Largent J; Oefelein MG; Adams WP
Plast Reconstr Surg; 2011 Sep; 128(3):651-661. PubMed ID: 21865998
[TBL] [Abstract][Full Text] [Related]
33. What's Your Micromort? A Patient-Oriented Analysis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Sieber DA; Adams WP
Aesthet Surg J; 2017 Sep; 37(8):887-891. PubMed ID: 29036945
[TBL] [Abstract][Full Text] [Related]
34. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
[TBL] [Abstract][Full Text] [Related]
35. Review of quality of online resources for breast implant associated anaplastic large cell lymphoma.
McMahon ME; Bollard SM; Potter SM; Hanson RP
J Plast Reconstr Aesthet Surg; 2020 Dec; 73(12):2239-2260. PubMed ID: 32473853
[No Abstract] [Full Text] [Related]
36. Epidemiological Profile in Portugal of Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cross-Sectional Study.
Cunha A; Horta R; Barreiro D
Acta Med Port; 2021 Aug; 34(9):572-579. PubMed ID: 33512315
[TBL] [Abstract][Full Text] [Related]
37. Risk of Breast Implant-Associated Anaplastic Large-Cell Lymphoma (BIA-ALCL).
Plast Surg Nurs; 2020; 40(4):E14. PubMed ID: 33259418
[No Abstract] [Full Text] [Related]
38. Risk of Breast Implant-Associated Anaplastic Large-Cell Lymphoma (BIA-ALCL).
Van Wicklin SA
Plast Surg Nurs; 2020; 40(4):193-194. PubMed ID: 33259417
[No Abstract] [Full Text] [Related]
39. BIA-ALCL and BIA-SCC: Updates on Clinical Features and Genetic Mutations for Latest Recommendations.
D'Orsi G; Giacalone M; Calicchia A; Gagliano E; Vannucchi L; Vanni G; Buonomo OC; Cervelli V; Longo B
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792976
[TBL] [Abstract][Full Text] [Related]
40. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma.
Kim J; Kang S; Choi MH; Park S; Nam SH; Park JU; Lee Y
Acta Biomater; 2023 Nov; 171():378-391. PubMed ID: 37683967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
